Protalix BioTherapeutics Q2 EPS $(0.25) Down From $(0.13) YoY

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.25) per share. This is a 92.31 percent decrease over losses of $(0.13) per share from the same period last year.

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.25) per share. This is a 92.31 percent decrease over losses of $(0.13) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Earnings Outlook For ServiceNow

ServiceNow (NYSE:NOW) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts estimate that ServiceNow will likely report an Earnings Per Share (EPS) of $1.43.

NOW